Author Correction: MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG

Nat Chem Biol. 2019 Dec;15(12):1249. doi: 10.1038/s41589-019-0409-0.

¹ Cancer Metabolism Laboratory, Francis Crick Institute, London, UK.
² Metabolomics Science Technology Platform, Francis Crick Institute, London, UK.
³ Peptide Chemistry Science Technology Platform, Francis Crick Institute, London, UK.
⁴ MRC-National Institute for Medical Research, London, UK.
⁵ Crick-GSK Biomedical LinkLabs, GSK Medicines Research Centre, Stevenage, UK.
⁶ Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
⁷ Massachusetts General Hospital Cancer Center & Department of Medicine, Harvard Medical School, Boston, MA, USA.
⁸ Department of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
⁹ Cancer Metabolism Laboratory, Francis Crick Institute, London, UK. dimitrios.anastasiou@crick.ac.uk.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.